125 related articles for article (PubMed ID: 26242718)
21. MR imaging in the early stage of 5-fluorouracil-induced leukoencephalopathy: DWI, MR perfusion, and MR spectroscopy.
Bang M; Weon YC; Yoo HJ; Kwon JH
Clin Neurol Neurosurg; 2012 Oct; 114(8):1185-8. PubMed ID: 22445615
[No Abstract] [Full Text] [Related]
22. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
Serrão VV; Feio AB
Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
[No Abstract] [Full Text] [Related]
23. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
24. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.
Iwatani K; Fujii N; Deguchi S; Tanimoto M
Int J Hematol; 2012 Dec; 96(6):683-4. PubMed ID: 23114968
[No Abstract] [Full Text] [Related]
25. [Capsule instead of infusion--new oral chemotherapy option].
Köhne CH
Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
[No Abstract] [Full Text] [Related]
26. A case of dermatomyositis triggered by tegafur.
Akiyama C; Osada A; Sou K; Yasaka N; Ohtake N; Furue M; Tamaki K
Acta Derm Venereol; 1997 Nov; 77(6):490. PubMed ID: 9394998
[No Abstract] [Full Text] [Related]
27. Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine.
Perrain V; Bihan K; Bompaire F; Houillier C; Jomier F; Leclercq D; Combret S; Mahé J; Ricard D; Berzero G; Psimaras D
Eur J Neurol; 2021 Jul; 28(7):2396-2402. PubMed ID: 33817933
[TBL] [Abstract][Full Text] [Related]
28. Capecitabine leukoencephalopathy.
Yasiry Z; Obeda MS; Batty R; Sharrack B
Pract Neurol; 2019 Jun; 19(3):270-271. PubMed ID: 30612099
[No Abstract] [Full Text] [Related]
29. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
[TBL] [Abstract][Full Text] [Related]
30. Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy.
Paul BS; Singh G; Bansal R; Paul G
J Postgrad Med; 2013; 59(2):135-7. PubMed ID: 23793316
[TBL] [Abstract][Full Text] [Related]
31. 5-fluorouracil-induced leukoencephalopathy with acute stroke-like presentation fulfilling criteria for recombinant tissue plasminogen activator therapy.
Kinno R; Kii Y; Uchiyama M; Owan Y; Yamazaki T; Fukui T
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):387-9. PubMed ID: 23422344
[TBL] [Abstract][Full Text] [Related]
32. Capecitabine-induced acute toxic leukoencephalopathy.
Obadia M; Leclercq D; Wasserman J; Galanaud D; Dormont D; Sahli-Amor M; Psimaras D; Pyatigorskaya N; Law-Ye B
Neurotoxicology; 2017 Sep; 62():1-5. PubMed ID: 28487252
[TBL] [Abstract][Full Text] [Related]
33. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for older patients with colorectal cancer.
Yusuf SW
Lancet; 2011 Aug; 378(9793):765; author reply 765-6. PubMed ID: 21872741
[No Abstract] [Full Text] [Related]
35. Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series.
Jose N; Joel A; Selvakumar RJ; Ramireddy J; John AO; Georgy JT; Singh A; Ram TS
J Egypt Natl Canc Inst; 2022 May; 34(1):22. PubMed ID: 35599280
[TBL] [Abstract][Full Text] [Related]
36. Acute reversible toxic leukoencephalopathy - a different entity.
Srinivasan S; Ali SZ
J Postgrad Med; 2013; 59(3):248. PubMed ID: 24029216
[No Abstract] [Full Text] [Related]
37. [Lethal interaction between 5-fluorouracil and brivudine].
García Herrera AN; Moncayola Vicén JC
An Sist Sanit Navar; 2018 Aug; 41(2):277-278. PubMed ID: 29943764
[No Abstract] [Full Text] [Related]
38. Cutaneous side-effects caused by Tegafur.
Revenga F
Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
[No Abstract] [Full Text] [Related]
39. [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
Gan To Kagaku Ryoho; 2003 May; 30(5):699-702. PubMed ID: 12795105
[TBL] [Abstract][Full Text] [Related]
40. Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
Summers RJ; Abramowsky CR; Cooper TM
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e19-22. PubMed ID: 23274378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
